Why trading on AIM?16 Jan 2025 12:28
Today's message from Deltex Medical waxes lyrically about the benefits of delisting from AIM.
I would say these reasons apply to enet but timed by a factor of 100.
" One of the most significant costs that the Group has to bear relates to the direct and indirect expenses associated with the Group maintaining its admission to trading on AIM ("Admission"). This includes but is not limited to fees payable to its professional advisers. These costs are estimated to total approximately £0.2 million per annum, representing approximately 10% of the Group's FY24 unaudited revenues. The board of directors of the Group (the "Board" or the "Directors") believes that these costs are disproportionate to the limited benefits that Admission provides to the Group and its shareholders ("Shareholders").
In addition to these Admission-related costs, the Board considers the regulatory environment associated with Admission, including the ongoing disclosure obligations, to be onerous for the Group taking into account its size and current market capitalisation, as well as impeding its commercial interests. The Board believes that cancelling its Admission will materially reduce the Group's recurring administrative and adviser expenses, whilst allowing the Board to focus on achieving its commercial and strategic goals. The Board has also considered the value that the current market capitalisation ascribes to the Company, the liquidity of the Ordinary Shares and the ability to raise further equity through public markets at an acceptable price should It be required."